Industry, clinical trials, and the cost of cancer drugs: An investor's perspective

被引：3

作者：

Fiorino, Tony

机构：

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 19期

关键词：

D O I：

10.1200/JCO.2007.11.1930

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：E21 / E23

页数：3

相关论文

共 3 条

[1] Estimating the cost of new drug development: Is it really $802 million? [J].

Adams, CP ;

Brantner, VV .

HEALTH AFFAIRS, 2006, 25 (02) :420-428

[2]

Berlin J, 2007, J CLIN ONCOL, V25, P444, DOI 10.1200/JCO.2006.10.3036

[3] Comparison of outcomes of phase II studies and subsequent randomized control studies using identical chemotherapeutic regimens [J].

Zia, MI ;

Siu, LL ;

Pond, GR ;

Chen, EX .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (28) :6982-6991